GlassScriptPhysician profile
Madeline Jensen
NPI 1659927390
$6,397.28
in general payments reported to CMS, 2019-2025
32 companies · $529 in 2025
The $529 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $748 · 2022: $1,461 · 2023: $1,771 · 2024: $1,887 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,016 · Education: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,015.70 |
| Education | $171.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $737.52 | 2023-2024 | Sotyktu |
| Abbvie INC. | $719.32 | 2021-2025 | |
| Genzyme Corporation | $614.50 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $563.02 | 2021-2025 | |
| Janssen Biotech, INC. | $460.59 | 2021-2025 | Tremfya |
| Ucb, INC. | $400.66 | 2022-2025 | Bimzelx, Cimzia |
| Regeneron Healthcare Solutions, INC. | $372.78 | 2021-2024 | Dupixent, Libtayo |
| Pfizer INC. | $360.83 | 2021-2024 | |
| Leo Pharma INC. | $356.28 | 2021-2024 | Adbry |
| Sun Pharmaceutical Industries INC. | $353.83 | 2021-2025 | Ilumya, Absorica Ld, Winlevi |
| Incyte Corporation | $271.96 | 2023-2025 | Opzelura |
| Dermavant Sciences, INC. | $252.52 | 2023-2024 | Vtama |
| Lilly USA, LLC | $215.50 | 2021-2025 | Taltz, Olumiant, Zepbound |
| Galderma Laboratories, L.P. | $135.29 | 2021-2025 | Nemluvio |
| Arcutis Biotherapeutics, INC. | $79.96 | 2023-2025 | Zoryve |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $65.61 | 2021 | |
| Foundation Medical, LLC | $54.70 | 2022 | |
| Mayne Pharma Commercial LLC | $46.95 | 2023-2024 | |
| Depuy Synthes Sales INC. | $38.28 | 2022 | |
| Organon LLC | $35.66 | 2025 | |
| Amgen INC. | $31.92 | 2022 | |
| Journey Medical Corporation | $30.18 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $29.54 | 2022 | |
| Strata Skin Sciences, INC. | $23.37 | 2022 | |
| Merck Sharp & Dohme LLC | $23.07 | 2022 | |
| Botanix Sb INC | $20.72 | 2025 | Sofdra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.81 | 2023 | Spevigo |
| Almirall LLC | $18.40 | 2022 | |
| Vyne Pharmaceuticals INC. | $18.36 | 2021 | |
| Kyowa Kirin, INC. | $17.64 | 2021 | |
| Verrica Pharmaceuticals INC. | $15.31 | 2024 | Ycanth |
| Kowa Pharmaceuticals America, INC. | $14.20 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madeline Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.